Celgene beats by $0.10, beats on revenue

• Celgene (NASDAQ:CELG): Q3 EPS of $1.58 beats by $0.10.
• Revenue of $2.98B (+27.9% Y/Y) beats by $150M.
• Shares +3.14% PM.
• Press Release